GlassScriptPhysician profile
Suna Panah
NPI 1326644873
$5,251.12
in general payments reported to CMS, 2019-2025
24 companies · $391 in 2025
The $391 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,500 · 2022: $265 · 2023: $735 · 2024: $360 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,856.10 | 2021 | |
| Arthrex, INC. | $1,377.84 | 2021 | |
| Smith+Nephew, INC. | $495.59 | 2021-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Organogenesis INC. | $429.32 | 2021-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Zimmer Biomet Holdings, INC. | $230.00 | 2021-2023 | Nextremity General Instrument, Genex |
| Next Science LLC | $149.43 | 2023-2024 | Xperience, Blastx, Surgx |
| Paratek Pharmaceuticals, INC. | $119.33 | 2021-2022 | |
| Convatec INC. | $97.24 | 2023-2025 | |
| Paladin Technology Solutions | $80.62 | 2023-2025 | |
| Averitas Pharma INC. | $72.73 | 2023-2024 | Qutenza |
| Stryker Corporation | $67.60 | 2023 | Ortholoc 2 Lapifuse, Phalinx |
| Urgo Medical North America, LLC | $47.68 | 2023-2024 | Urgok2 |
| Solventum Corporation | $42.53 | 2025 | Activ.A.C., Promogran Prisma |
| Medtronic, INC. | $29.41 | 2024 | Intellis Adaptivestim |
| Hartmann USA, INC. | $23.97 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $21.84 | 2024 | Motoband |
| Orthofix Medical, INC. | $20.87 | 2025 | Physio-Stim |
| Kerecis Limited | $18.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Biotissue Holdings INC. | $16.84 | 2021 | |
| Bioventus LLC | $16.32 | 2021 | |
| Misonix INC | $12.55 | 2021 | |
| Nabriva Therapeutics, Plc | $12.24 | 2021 | |
| Heron Therapeutics, INC. | $9.17 | 2021 | |
| Lifenet Health | $3.73 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suna Panah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.